Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 191
9
Diseases
4
Unique genes
0.384
Avg. similarity score
15q24 microdeletion
Most-connected disease (6 links)
Disease
Searched: Syndromic intellectual disability and autism spectrum disorder
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Syndromic intellectual disability and autism spectrum disorder
15q24 microdeletion
Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies
Cleft palate cardiac defects impaired intellectual development
Cleft palate congenital heart defect intellectual disability syndrome due to 15q14 microdeletion
Disorder with cleft palate, cardiac defects, and developmental delay
Cardiac, facial, and digital anomalies with developmental delay
Witteveen-kolk syndrome
Chromosome 15q24 deletion syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| 15q24 microdeletion | 6 | 6 | 2 |
| Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies | 5 | 5 | 1 |
| Cleft palate cardiac defects impaired intellectual development | 5 | 5 | 1 |
| Cleft palate congenital heart defect intellectual disability syndrome due to 15q14 microdeletion | 5 | 5 | 1 |
| Disorder with cleft palate, cardiac defects, and developmental delay | 5 | 5 | 1 |
| Cardiac, facial, and digital anomalies with developmental delay | 4 | 4 | 2 |
| Witteveen-kolk syndrome | 3 | 3 | 2 |
| Chromosome 15q24 deletion syndrome | 2 | 2 | 1 |
| Syndromic intellectual disability and autism spectrum disorder | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| MEIS2 | 6 / 9 | 15q24 microdeletion, Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies, Cardiac, facial, and digital anomalies with developmental delay, Cleft palate cardiac defects impaired intellectual development and 2 more |
| SIN3A | 3 / 9 | 15q24 microdeletion, Chromosome 15q24 deletion syndrome, Witteveen-kolk syndrome |
| SIN3B | 2 / 9 | Syndromic intellectual disability and autism spectrum disorder, Witteveen-kolk syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Regulation of lipid metabolism by PPARalpha | Reactome | 2 / 20 | 300× | 1.58e-5 | 4.28e-4 ✓ sig. |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | Reactome | 2 / 97 | 61.9× | 3.83e-4 | 5.44e-3 ✓ sig. |
| Loss of MECP2 binding ability to 5mC-DNA | Reactome | 1 / 3 | 1,001× | 9.99e-4 | 1.13e-2 ✓ sig. |
| Regulation of MECP2 expression and activity | Reactome | 1 / 6 | 500× | 2.00e-3 | 1.90e-2 ✓ sig. |
| SUMOylation of transcription cofactors | Reactome | 1 / 41 | 73.2× | 1.36e-2 | 6.85e-2 |
| TGF-beta signaling pathway | KEGG | 1 / 108 | 27.8× | 3.55e-2 | 1.19e-1 |
| Thyroid hormone signaling pathway | KEGG | 1 / 122 | 24.6× | 4.00e-2 | 1.28e-1 |
| Transcriptional misregulation in cancer | KEGG | 1 / 198 | 15.2× | 6.43e-2 | 1.67e-1 |
| Epstein-Barr virus infection | KEGG | 1 / 204 | 14.7× | 6.62e-2 | 1.70e-1 |
| Huntington disease | KEGG | 1 / 308 | 9.7× | 9.87e-2 | 2.15e-1 |
| Antigen processing: Ubiquitination & Proteasome degradation | Reactome | 1 / 309 | 9.7× | 9.90e-2 | 2.15e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| response to methylglyoxal | GO:0051595 | 1 / 1 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |
| cellular response to tert-butyl hydroperoxide | GO:0072736 | 1 / 1 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |
| negative regulation of transcription by RNA polymerase II | GO:0000122 | 3 / 1,002 | 14.0× | 5.90e-4 | 1.06e-2 ✓ sig. |
| negative regulation of cell migration | GO:0030336 | 2 / 190 | 49.2× | 6.09e-4 | 1.09e-2 ✓ sig. |
| positive regulation of cardiac muscle myoblast proliferation | GO:0110024 | 1 / 3 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |
| regulation of hormone levels | GO:0010817 | 1 / 5 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| negative regulation of circadian rhythm | GO:0042754 | 1 / 8 | 584× | 1.71e-3 | 1.96e-2 ✓ sig. |
| cellular response to dopamine | GO:1903351 | 1 / 8 | 584× | 1.71e-3 | 1.96e-2 ✓ sig. |
| regulation of DNA-templated transcription | GO:0006355 | 3 / 1,454 | 9.6× | 1.77e-3 | 1.99e-2 ✓ sig. |
| protein K29-linked ubiquitination | GO:0035519 | 1 / 12 | 389× | 2.57e-3 | 2.40e-2 ✓ sig. |
| regulation of axon extension | GO:0030516 | 1 / 13 | 359× | 2.78e-3 | 2.51e-2 ✓ sig. |
| response to growth factor | GO:0070848 | 1 / 14 | 334× | 2.99e-3 | 2.59e-2 ✓ sig. |
| cerebral cortex neuron differentiation | GO:0021895 | 1 / 16 | 292× | 3.42e-3 | 2.78e-2 ✓ sig. |
| negative regulation of myeloid cell differentiation | GO:0045638 | 1 / 19 | 246× | 4.06e-3 | 3.03e-2 ✓ sig. |
| negative regulation of stem cell population maintenance | GO:1902455 | 1 / 21 | 222× | 4.49e-3 | 3.17e-2 ✓ sig. |